ARCT
Price
$13.72
Change
-$0.69 (-4.79%)
Updated
Jun 27, 12:48 PM (EDT)
Capitalization
390.81M
45 days until earnings call
ELTX
Price
$7.87
Change
-$0.03 (-0.38%)
Updated
Jun 27, 12:51 PM (EDT)
Capitalization
126.38M
Interact to see
Advertisement

ARCT vs ELTX

Header iconARCT vs ELTX Comparison
Open Charts ARCT vs ELTXBanner chart's image
Arcturus Therapeutics Holdings
Price$13.72
Change-$0.69 (-4.79%)
Volume$101
Capitalization390.81M
Elicio Therapeutics
Price$7.87
Change-$0.03 (-0.38%)
Volume$600
Capitalization126.38M
ARCT vs ELTX Comparison Chart in %
Loading...
ARCT
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
ELTX
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
View a ticker or compare two or three
VS
ARCT vs. ELTX commentary
Jun 27, 2025

To compare these two companies we present long-term analysis, their fundamental ratings and make comparative short-term technical analysis which are presented below. The conclusion is ARCT is a StrongBuy and ELTX is a Hold.

Interact to see
Advertisement
COMPARISON
Comparison
Jun 27, 2025
Stock price -- (ARCT: $14.41 vs. ELTX: $7.90)
Brand notoriety: ARCT and ELTX are both not notable
Both companies represent the Biotechnology industry
Current volume relative to the 65-day Moving Average: ARCT: 121% vs. ELTX: 75%
Market capitalization -- ARCT: $390.81M vs. ELTX: $126.38M
ARCT [@Biotechnology] is valued at $390.81M. ELTX’s [@Biotechnology] market capitalization is $126.38M. The market cap for tickers in the [@Biotechnology] industry ranges from $113.86B to $0. The average market capitalization across the [@Biotechnology] industry is $2.32B.

Long-Term Analysis

It is best to consider a long-term outlook for a ticker by using Fundamental Analysis (FA) ratings. The rating of 1 to 100, where 1 is best and 100 is worst, is divided into thirds. The first third (a green rating of 1-33) indicates that the ticker is undervalued; the second third (a grey number between 34 and 66) means that the ticker is valued fairly; and the last third (red number of 67 to 100) reflects that the ticker is undervalued. We use an FA Score to show how many ratings show the ticker to be undervalued (green) or overvalued (red).

ARCT’s FA Score shows that 0 FA rating(s) are green whileELTX’s FA Score has 1 green FA rating(s).

  • ARCT’s FA Score: 0 green, 5 red.
  • ELTX’s FA Score: 1 green, 4 red.
According to our system of comparison, ELTX is a better buy in the long-term than ARCT.

Short-Term Analysis

It is best to consider a short-term outlook for a ticker by using Technical Analysis (TA) indicators. We use Odds of Success as the percentage of outcomes which confirm successful trade signals in the past.

If the Odds of Success (the likelihood of the continuation of a trend) for each indicator are greater than 50%, then the generated signal is confirmed. A green percentage from 90% to 51% indicates that the ticker is in a bullish trend. A red percentage from 90% - 51% indicates that the ticker is in a bearish trend. All grey percentages are below 50% and are considered not to confirm the trend signal.

ARCT’s TA Score shows that 5 TA indicator(s) are bullish while ELTX’s TA Score has 6 bullish TA indicator(s).

  • ARCT’s TA Score: 5 bullish, 4 bearish.
  • ELTX’s TA Score: 6 bullish, 5 bearish.
According to our system of comparison, both ARCT and ELTX are a good buy in the short-term.

Price Growth

ARCT (@Biotechnology) experienced а +16.68% price change this week, while ELTX (@Biotechnology) price change was -0.75% for the same time period.

The average weekly price growth across all stocks in the @Biotechnology industry was +9.93%. For the same industry, the average monthly price growth was +39.30%, and the average quarterly price growth was +17.52%.

Reported Earning Dates

ARCT is expected to report earnings on Aug 11, 2025.

ELTX is expected to report earnings on Mar 31, 2025.

Industries' Descriptions

@Biotechnology (+9.93% weekly)

Biotechnology involves genetic or protein engineering to produce medicines/therapies for treating and preventing ailments. The industry also provides crucial ingredients for diagnostics. This multi-billion-dollar industry is heavily focused on research and development, as companies attempt to continually come up with cutting-edge solutions for health. New discoveries for the treatment of diseases provide opportunities for growth for a company in this industry. Discoveries, however, must pass the regulatory approval from the U.S. Food and Drug Administration (FDA) before they can make it to markets. Amgen Inc., Gilead Sciences, Inc. and Celgene Corporation are examples of companies in this industry.

SUMMARIES
Loading...
FUNDAMENTALS
Fundamentals
ARCT($391M) has a higher market cap than ELTX($126M). ELTX YTD gains are higher at: 54.902 vs. ARCT (-15.085). ELTX has higher annual earnings (EBITDA): -49.52M vs. ARCT (-63.92M). ARCT has more cash in the bank: 217M vs. ELTX (18.4M). ELTX has less debt than ARCT: ELTX (5.79M) vs ARCT (42.7M). ARCT has higher revenues than ELTX: ARCT (131M) vs ELTX (0).
ARCTELTXARCT / ELTX
Capitalization391M126M310%
EBITDA-63.92M-49.52M129%
Gain YTD-15.08554.902-27%
P/E RatioN/A5.96-
Revenue131M0-
Total Cash217M18.4M1,179%
Total Debt42.7M5.79M737%
FUNDAMENTALS RATINGS
ARCT: Fundamental Ratings
ARCT
OUTLOOK RATING
1..100
15
VALUATION
overvalued / fair valued / undervalued
1..100
48
Fair valued
PROFIT vs RISK RATING
1..100
100
SMR RATING
1..100
95
PRICE GROWTH RATING
1..100
55
P/E GROWTH RATING
1..100
100
SEASONALITY SCORE
1..100
50

Tickeron ratings are formulated such that a rating of 1 designates the most successful stocks in a given industry, while a rating of 100 points to the least successful stocks for that industry.

TECHNICAL ANALYSIS
Technical Analysis
ARCTELTX
RSI
ODDS (%)
Bearish Trend 2 days ago
90%
Bearish Trend 2 days ago
80%
Stochastic
ODDS (%)
Bearish Trend 2 days ago
77%
Bullish Trend 2 days ago
73%
Momentum
ODDS (%)
Bullish Trend 2 days ago
81%
Bearish Trend 2 days ago
87%
MACD
ODDS (%)
Bullish Trend 2 days ago
81%
Bearish Trend 2 days ago
84%
TrendWeek
ODDS (%)
Bullish Trend 2 days ago
83%
Bearish Trend 2 days ago
89%
TrendMonth
ODDS (%)
Bullish Trend 2 days ago
80%
Bullish Trend 2 days ago
81%
Advances
ODDS (%)
Bullish Trend 2 days ago
81%
Bullish Trend 8 days ago
79%
Declines
ODDS (%)
Bearish Trend 23 days ago
87%
Bearish Trend 2 days ago
88%
BollingerBands
ODDS (%)
Bearish Trend 2 days ago
90%
Bearish Trend 2 days ago
90%
Aroon
ODDS (%)
Bullish Trend 3 days ago
83%
Bullish Trend 2 days ago
89%
View a ticker or compare two or three
Interact to see
Advertisement
ARCT
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
ELTX
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
Interesting Tickers
1D
1W
1M
1Q
6M
1Y
5Y
1 Day
MFs / NAMEPrice $Chg $Chg %
AEMMX12.00N/A
N/A
American Century Emerging Markets A
MPGSX11.45N/A
N/A
MassMutual Disciplined Gr R5
BPTRX195.54N/A
N/A
Baron Partners Retail
RIEIX12.79N/A
N/A
RBC International Equity I
EQNRX22.18N/A
N/A
MFS Equity Income R1

ARCT and

Correlation & Price change

A.I.dvisor indicates that over the last year, ARCT has been loosely correlated with TRDA. These tickers have moved in lockstep 52% of the time. This A.I.-generated data suggests there is some statistical probability that if ARCT jumps, then TRDA could also see price increases.

1D
1W
1M
1Q
6M
1Y
5Y
Ticker /
NAME
Correlation
To ARCT
1D Price
Change %
ARCT100%
+3.30%
TRDA - ARCT
52%
Loosely correlated
-0.57%
ABCL - ARCT
51%
Loosely correlated
-1.58%
RGNX - ARCT
51%
Loosely correlated
+2.46%
MRNA - ARCT
50%
Loosely correlated
+2.53%
RXRX - ARCT
50%
Loosely correlated
+4.65%
More

ELTX and

Correlation & Price change

A.I.dvisor tells us that ELTX and PCVX have been poorly correlated (+30% of the time) for the last year. This A.I.-generated data suggests there is low statistical probability that ELTX and PCVX's prices will move in lockstep.

1D
1W
1M
1Q
6M
1Y
5Y
Ticker /
NAME
Correlation
To ELTX
1D Price
Change %
ELTX100%
-1.50%
PCVX - ELTX
30%
Poorly correlated
-0.63%
CORT - ELTX
29%
Poorly correlated
+0.46%
LVTX - ELTX
27%
Poorly correlated
-0.71%
ARCT - ELTX
27%
Poorly correlated
+3.30%
VOR - ELTX
27%
Poorly correlated
+60.53%
More